Search results
AskBio commences subject recruitment in Phase II Parkinson’s trial
Clinical Trials Arena· 10 hours agoThe double-blind, randomised, surgery-controlled trial is designed to assess the safety and efficacy...
Steps to make UP malaria-free by '27 | Lucknow News - Times of India
The Times of India· 6 days agoLucknow: In its effort to make UP a malaria-free state by 2027, govt has increased focus on...
Shukla will launch “Dastak” campaign today | Central India's Premier English Daily
Central Chronicle· 2 days agoMinister of State for Public Health and Medical Education Narendra Shivaji Patel will also be present. Dastak Abhiyan is conducted every year in the state to identify childhood ...
CKD market to grow at CAGR of 19.6% from $2.2b in 2023 to $13.5b in 2033 - ET HealthWorld
The Economic Times· 8 hours agoGlobalData’s latest report 'Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis',...
What to Do If Your Doctor Isn’t Taking Your Period Pain Seriously
Self· 4 hours agoEven seemingly unrelated chronic conditions, like Crohn’s disease, for example, can flare up and...
FDA expands Fractyl endoscopy trial to include untreated diabetes patients
Medical Device Network· 1 day agoAt...significant weight loss after stopping tirzepatide. Rajagopalan added: “If successful and...
Gujarat government runs statewide campaign to eradicate Sickle cell disease - ET HealthWorld
The Economic Times· 2 days agoNew Delhi: The Gujarat government commenced a statewide campaign to eradicate Sickle cell disease....
Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease
Pharmaceutical Technology· 5 days agoIt has shown potential as the only IL-23 inhibitor providing both subcutaneous and intravenous...
Novo Nordisk invests $4.1bn in manufacturing facility in NC
Pharmaceutical Technology· 1 day agoIn Clayton and across our global manufacturing sites, we are driven by one purpose: to deliver more...
GSK’s Omjjara gains approval in Japan for myelofibrosis treatment
Pharmaceutical Technology· 1 day ago"GSK’s Omjjara gains approval in Japan for myelofibrosis treatment" was originally created and...